| Alexion Pharma GmbH - Ultomiris 300 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 67278 | | 01 | | Ultomiris 300 mg/30 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L04AJ02 | | Ravulizumab | | 20.01.2020 | | |
|
| Composition |
| ravulizumabum 300 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 30 ml corresp. natrium 115 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Ravulizumabum | 300mg / 30ml |
| | BAG: Active Agent | Dose |
|---|
| Ravulizumabum | 300 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 4035.23 | 4181.20 | A | SL | No |
|
